Bone Biologics Corp 4
4 · Bone Biologics Corp · Filed Dec 30, 2015
Insider Transaction Report
Form 4
Walsh Deina H
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-12-28+239,825→ 239,825 totalExercise: $1.59Exp: 2025-12-27→ Common Stock (239,825 underlying) - Award
Employee Stock Option (Right to Buy)
2015-12-28+465,795→ 465,795 totalExercise: $1.59Exp: 2025-12-27→ Common Stock (465,795 underlying)
Footnotes (2)
- [F1]159,883 shares subject to the option are immediately exercisable and the remaining shares subject to the option shall vest and become exercisable on November 4, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2015 Equity Incentive Plan (the "Plan")) on such vesting date.
- [F2]1/3 of the shares subject to the option shall vest and become exercisable on each of December 1, 2016, December 1, 2017 and December 1, 2018, subject to the Reporting Person's Continuous Service (as defined in the Plan) on each such vesting date.